Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 729,400 | 1,257,100 | 1,317,600 | 870,300 | 825,400 |
| Marketable Securities | 447,100 | 1,066,900 | 583,100 | 782,800 | 1,063,700 |
| Receivables | 1,468,700 | 1,400,300 | 1,403,900 | 1,377,200 | 1,233,500 |
| Inventories | 1,093,500 | 1,067,800 | 1,171,500 | 1,142,600 | 1,080,500 |
| Other current assets | 994,500 | 592,700 | 332,100 | 263,000 | 301,700 |
| TOTAL | $4,733,200 | $5,384,800 | $4,808,200 | $4,435,900 | $4,504,800 |
| Non-Current Assets | |||||
| PPE Net | 2,632,500 | 2,305,100 | 2,381,000 | 2,109,800 | 1,784,100 |
| Investments And Advances | 586,700 | 601,400 | 1,337,800 | 1,422,700 | 1,103,300 |
| Other Non-Current Assets | 1,378,500 | 1,298,800 | 1,107,600 | 1,083,600 | 932,600 |
| TOTAL | $4,597,700 | $4,205,300 | $4,826,400 | $4,616,100 | $3,820,000 |
| Total Assets | $9,330,900 | $9,590,100 | $9,634,600 | $9,052,000 | $8,324,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 479,100 | 456,400 | 462,900 | 450,300 | 401,400 |
| Accrued Expenses | 408,600 | 332,900 | 287,600 | 283,600 | 236,500 |
| Other current liabilities | 770,900 | 779,900 | 620,400 | 576,000 | 479,200 |
| TOTAL | $3,443,600 | $3,217,400 | $3,420,500 | $3,116,900 | $2,911,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 570,500 | 571,300 | 396,600 | 193,300 | 190,600 |
| Other Non-Current Liabilities | 1,261,900 | 935,900 | 456,300 | 156,700 | 136,100 |
| TOTAL | $2,021,800 | $1,654,100 | $1,187,800 | $843,100 | $877,400 |
| Total Liabilities | $5,465,400 | $4,871,500 | $4,573,900 | $3,960,000 | $3,789,000 |
| Shareholders' Equity | |||||
| Common Shares | 33,900 | 33,700 | 33,200 | 16,500 | 16,500 |
| Retained earnings | 5,240,700 | 5,119,300 | 4,794,900 | 4,509,900 | 4,105,400 |
| Other shareholders' equity | -657,800 | 45,700 | 157,700 | 256,000 | 47,400 |
| TOTAL | $3,865,500 | $4,718,600 | $5,026,300 | $5,092,000 | $4,535,800 |
| Total Liabilities And Equity | $9,330,900 | $9,590,100 | $9,600,200 | $9,052,000 | $8,324,800 |